LOAN AND SECURITY AGREEMENTLoan and Security Agreement • March 17th, 2014 • Agile Therapeutics Inc
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of December 14, 2012 (the “Effective Date”) among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (“Oxford”), as collateral agent (in such capacity, “Collateral Agent”), the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time including Oxford in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”), and Agile Therapeutics, Inc., a Delaware corporation with offices located at 101 Poor Farm Road, Princeton, NJ 08540 (“Borrower”), provides the terms on which the Lenders shall lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENTDevelopment, License and Commercialization Agreement • March 17th, 2014 • Agile Therapeutics Inc • New York
This Development, License and Commercialization Agreement (this “Agreement”) is entered into as of October 18, 2006 (the “Effective Date”) between Corium International, Inc., a Delaware corporation having its principal place of business at 2686 Middlefield Road, Redwood City, CA 94063, (“Corium”), and Agile Therapeutics, Inc., a Delaware corporation, having its principal place of business at 366 Wall Street, Princeton, NJ 08540, (“Agile”).
FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 17th, 2014 • Agile Therapeutics Inc • Delaware
This FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT dated as of July 18, 2012 among Agile Therapeutics, Inc. (the “Company”), a Delaware corporation; those persons listed on Schedule A hereto who are signatories to this Agreement (individually an “Investor” and collectively the “Investors”); and those persons listed on Schedule B hereto who are signatories to this Agreement (individually a “Management Stockholder” and collectively the “Management Stockholders”).
CONSULTING AGREEMENTConsulting Agreement • March 17th, 2014 • Agile Therapeutics Inc • New Jersey
This CONSULTING AGREEMENT (this “Agreement”) is entered into and effective as of this 24th day of May, 2012 (the “Effective Date”), by and between AGILE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and SMARTPHARMA LLC, a New Jersey limited liability company (the “Consultant”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2014 • Agile Therapeutics Inc • New Jersey
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 11, 2010, by and between AGILE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and AL ALTOMARI, an individual residing at 8 Yeger Drive, Lawrenceville, NJ 08648 (the “Executive”), collectively referred to as the “parties.”
